FLT1 and neoplasm: When tested in vivo actein significantly inhibited blood vessel formation and decreased tumor size and metastasis through reducing the expression of angiogenic proteins (CD34 and Factor VIII) and metastasis-related VEGFR1 and C-X-C chemokine receptor type 4 (CXCR4) genes (128).